Conclusion: The study will contribute to the orientation of finding lead compounds capable of inhibiting the receptor GP IIb / IIIa, thereby shortening the time to search for new substances in the treatment of thrombotic diseases. Key words: Thrombosis, GP IIb / IIIa receptor, in silico, QSAR, molecular docking, flavonoid, curcumin.